Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pharmacoepidemiological Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice in Germany

NCT01947959 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01947959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01947959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pharmacoepidemiological Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice in Germany
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
December 22, 2011
Completion date
September 30, 2020
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, atrial fibrillation, pulmonary embolism, venous thrombosis